Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000895345-25-000071·Whitehawk Therapeutics, Inc.
Schedule 13G ownership disclosure
Whitehawk Therapeutics, Inc.
Common Stock, par value $0.0001 per share · CUSIP: 00032Q104
Event date: 2024-12-31
- Filing-level shares
- 659
- Percent of class
- 0%
- Satter Muneer A
Shares: 659 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895345-25-000071
- Form type
- SCHEDULE 13G/A
- Filer
- Whitehawk Therapeutics, Inc.
- CIK
- CIK 1422142
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership